Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

Summary

Bronchiolitis obliterans (BO) is a chronic lung disease which was initiated with injury of the bronchiolar epithelium and resulted in nonuniform luminal obliteration or narrowing. Among children, the most common form of BO is post-infectious BO with a lack of treatment guidelines or standard therapy. In this study, an open, single-armed study is performed to preliminarily evaluate the safety and efficacy of airway basal stem cells on treatment of pediatric BO.

Timeline

Start

2025-11-11

Primary completion

2027-11

Completion

2027-11

Drugs

Indications